Learning Objectives:

1. To identify patients with NAFLD at risk of advanced liver disease.

2. To understand the application of available medications for associated comorbidities that can benefit patients with NASH.

3. To be aware of the drugs nearing FDA approval for NASH

Session date: 
06/14/2023 - 5:30pm to 6:30pm CDT
Zoom Webinar
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Mary Rinella, MD